ArticleBJUI compass2026

Omission of contralateral biopsies in unilateral MRI-suspicious prostate cancer has minimal impact on clinical risk assessment.

Stijn M van den Bosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.